NCT05936528View on ClinicalTrials.gov

Lactoferrin Use in ICU Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

December 29, 2025

Primary Completion Date

December 29, 2027

Study Completion Date

December 29, 2027

Conditions
Critical Illness
Interventions
DRUG

Lactoferrin

antioxidant, immunomodulatory, anti-inflammatory, antimicrobial effect

DRUG

Antioxidant therapies

Acetyl cysteine 600 mg / 12 hr

DRUG

Dexamethasone

dexamethasone I.V 8 mg / day

DRUG

Antibacterial therapies

Antibacterial drugs in their approved doses

Trial Locations (1)

Unknown

Mansoura University hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University Hospital

OTHER